GlaxoSmithKline Raises Bet on Potential Blockbuster AIDS Drug With New Shionogi, Inc. Deal

GlaxoSmithKline has raised its bet on a promising drug for HIV/AIDS by redrawing a deal with Japan's Shionogi which gives it a much bigger economic interest in the new product.Dolutegravir, a once-dai…

---

GSK raises bet on AIDS drug with new Shionogi deal

LONDON/TOKYO (Reuters) - GlaxoSmithKline has raised its bet on a promising drug for HIV/AIDS by redrawing a deal with Japan's Shionogi which gives it a much bigger economic interest in the new product…

---

GSK raises bet on once-a-day AIDS drug with new Shionogi deal

LONDON/TOKYO (Reuters) - GlaxoSmithKline has raised its bet on a promising drug for HIV/AIDS by redrawing a deal with Japan's Shionogi, giving it a much bigger economic interest in the new product. D…

---

ViiV/Shionogi’s dolutegravir beats Gilead drug in HIV study

ViiV/Shionogi's dolutegravir beats Gilead drug in HIV study…

---